34 Spam-Free Article(s) Found
https://www.zacks.com/stock/news/2202040/is-janus-henderson-research-d-jnrfx-a-strong-mutual-fund-pick-right-now?cid=CS-ZC-FT-mutual_fund_equity_report-2202040
Dec 26, 2023 - Mutual Fund Report for JNRFX
zc:581260799087643752
0
https://www.nrn.com/fast-casual/captain-d-s-signs-franchise-development-agreements-new-jersey-and-georgia
Dec 19, 2023 - New franchisees bring more conversion opportunities to fast casual seafood leader
0
nrn:4463330223299085945
0
https://seekingalpha.com/article/4657977-biocryst-factor-d-inhibitor-data-in-2024-should-be-watched-closely?source=feed_all_articles
Dec 14, 2023 - BioCryst had $399.2 million in cash as of September 30th 2023; enough cash to fund its operations for at least the next 12 months. Read more here.
0
sa:4843681426392448271
0
https://www.zacks.com/stock/news/2195113/sanofi-sny-posts-upbeat-long-term-outlook-enhances-r-d-focus?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2195113
Dec 07, 2023 - Sanofi (SNY) aims to generate annual sales of over 10 billion euros by 2030, driven by recently launched and potential new products. It intends to enhance R&D focus to become a market leader in immunology.
zc:1484433858443186251
0